Retail sale of pharmaceutical products
SANA PHARMA NORGE AS
Revenue 2025
NOK 1.2m
Operating profit
NOK −1.4m
Equity
NOK −3.1m
Incorporated
2013
Share capital
NOK 100,000
Key figures · 2025
Current ratio
0.28
Equity ratio
-257.7%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -119.8% | |
| Net margin (%%) | -119.8% | |
| Return on assets (%%) | -118.0% | |
| Likviditet | ||
| Current ratio | 0.28 | |
| Working capital | −3.1m | |
| Soliditet | ||
| Equity ratio (%%) | -257.7% | |
| Debt-to-equity ratio | -1.39 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.